Parabolic Drugs (Delisted) share news and announcements

BSE: 533211Pharmaceuticals & Biotechnology

Last traded ₹5.50 on 25 Jan 2021

Delisted on 11 Aug 2021.

Parabolic Drugs share news and announcements

677 announcements, routine notices left out, newest first. Page 12 of 14.

Feb 2012
- 1 Feb · Board meeting
  Inter-alia, to consider and take on record the unaudited financial results of the Company for the quarter ended December 31, 2011.
Dec 2011
Nov 2011
Oct 2011
- 31 Oct · Board meeting
  Inter-alia, to consider and take on record the unaudited financial results of the Company for the quarter ended September 30, 2011.
- 31 Oct · Disclosure
  Parabolic Drugs Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE: (opens in a new tab)
- 31 Oct · Business
  Vide its letter dated October 31, 2011 regarding a press release, titled "Parabolic Drugs gets Japanese nod for Cephalosporin Drugs". (opens in a new tab)
- 31 Oct · Parabolic Drugs gets Japanese nod for Cephalosporin Drugs
  Press Release titled "Parabolic Drugs gets Japanese nod for Cephalosporin Drugs" Press Release : "The Company has received .... (opens in a new tab)
- 29 Oct · Disclosure
  PNG Trading Pvt Ltd has submitted the disclosure under Regulation 13(4) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE (opens in a new tab)
- 24 Oct · Disclosure
  Parabolic Drugs Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE: (opens in a new tab)
- 24 Oct · Disclosure
  PNG Trading Pvt Ltd has submitted the disclosure under Regulation 13(4) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE (opens in a new tab)
- 21 Oct · Meeting
  Members at the 15th Annual General Meeting (AGM) of the Company held on September 29, 2011, inter alia, have accorded to the following: .... (opens in a new tab)
- 21 Oct · Meeting
  Minutes of the Annual General Meeting of the Company held on September 29, 2011. (opens in a new tab)
- 19 Oct · Disclosure
  Parabolic Drugs Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE: (opens in a new tab)
- 18 Oct · Disclosure
  PNG Trading Pvt Ltd has submitted the disclosure under Regulation 13(4) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE (opens in a new tab)
- 14 Oct · Disclosure
  Parabolic Drugs Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE: (opens in a new tab)
- 14 Oct · Management
  Members of the Company at its Annual General Meeting held on September 29, 2011: (1) Appointed Mr. Manmohan Lal Sarin as a Director in place of Mr. Pardeep Diwan, who retired by rotation in accordance with the provisions of Articles of Association of the Company; (2) Approved the appointments of Mr. Gurpreet Singh Sandhu and Mr. Nikhil Goel as the Directors of the Company w.e.f September 29, 2011. (3) Approved the appointment of Mr. Gurpreet Singh Sandhu as the Executive Director of the Company w.e.f November 01, 2010 to October 31, 2012.
- 12 Oct · Disclosure
  Parabolic Drugs Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE: (opens in a new tab)
- 11 Oct · Disclosure
  PNG Trading Pvt Ltd has submitted the disclosure under Regulation 13(4) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE (opens in a new tab)
- 10 Oct · Meeting
  Members at the Annual General Meeting (AGM) of the Company held on September 29, 2011 inter alia, have transacted the following: 1. ....
- 10 Oct · Disclosure
  Parabolic Drugs Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE: (opens in a new tab)
- 7 Oct · Disclosure
  PNG Trading Pvt Ltd has submitted the disclosure under Regulation 13(4) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE (opens in a new tab)
- 5 Oct · Disclosure
  Parabolic Drugs Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE: (opens in a new tab)
- 4 Oct · Disclosure
  PNG Trading Pvt Ltd has submitted the disclosure under Regulation 13(4) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE (opens in a new tab)
Sep 2011